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Summary
 
We have established a new clonal assay system that can evenly support the development of T
and natural killer (NK) cells. With this system, we show that all T cell progenitors in the earliest
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 fetal thymus (FT) cell population retain NK potential, and that the
NK lineage–committed progenitors (p-NK) also exist in this population. T cell lineage–committed
progenitors (p-T), which are unable to generate NK cells, first appear at the CD44
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 stage in day 12 FT. The proportion of p-T markedly increases during the transi-
tion from the CD44
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CD25
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 stage to the CD44
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CD25
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 stage in day 14 FT. On the other hand,
p-NK preferentially increase in number at the CD44
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CD25
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 stage between days 12 and 14 of
gestation. The production of p-NK continues up to the CD44
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CD25
 
1
 
 stage, but ceases before the
rearrangement of T cell receptor 
 
b
 
 chain genes. It was further shown that the CD44
 
1
 
CD25
 
2
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population of day 14 FT exclusively contains p-NK. These results indicate that the
earliest T cell progenitor migrating into the FT is T/NK bipotent, and strongly suggest that the
bipotent progenitor continuously produces p-NK and p-T until the CD44
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CD25
 
1
 
 stage.
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T
 
he T cell system is composed of functionally distinct sub-
sets, including helper T cells, killer T cells, and T cells
mediating delayed type hypersensitivity, and these T cells
comprise millions of clones expressing the TCR that recog-
nize different antigens. NK cells carry a similar function as
killer T cells, in that they discriminate virus-infected cells and
some neoplastic cells from normal healthy cells, and kill such
cells (1, 2). However, NK cells are distinct from T cells since
they do not express a TCR (3), and NK cell development
is independent of the thymus (4). Nevertheless, experimen-
tal evidence has been accumulated proposing that T and
NK cells are derived from a common progenitor (5–7).
There has been more than a decade of dispute about the
characteristics of T cell progenitors migrating into the thymus
(8–11). Early studies made by marking the bone marrow pro-
genitors with chromosome aberrations (12) or bacterial gene
introduction (13–15) suggested that the progenitors migrat-
ing into the thymus are committed to the T cell lineage.
On the other hand, it has been shown that the earliest pop-
ulation of thymus cells was able to generate not only T but
also B and NK cells when transferred into irradiated recipi-
ents (16, 17). In the fetus, the earliest population of thymus
cells has also been shown to retain myeloid potential (18,
19), suggesting that a common progenitor for these lineages
exists in the thymus. However, such experiments where
cell populations are used as the progenitor source are usu-
ally ineffective in discriminating the activity of a mixture of
unipotent progenitors for different lineages from that of a
common progenitor. To avoid the dilemma of cell popula-
tions, we have developed a clonal assay system, the multi-
lineage progenitor (MLP)
 
1
 
 assay (20), which is capable of
determining the developmental potential of single progeni-
tors toward T, B, and myeloid lineages. With the MLP as-
say, we have shown that the earliest population in fetal thy-
mus (FT) does not contain multipotent progenitors but
rather contains progenitors restricted to the T, B, or mye-
loid lineage (21). Although this study clarified that thymic
T cell progenitors are distinct from myeloid and B cell pro-
genitors, it remained unclear whether the T cell progeni-
tors we determined retain the potential to generate NK
cells.
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Abbreviations used in this paper:
 
 APC, allophycocyanin; B6, C57BL/6;
dGuo, deoxyguanosine; dpc, day(s) postcoitum; FcR, Fc
 
g
 
RII/III; FL, fetal
liver; FT, fetal thymus; HOS, high oxygen submersion; Lin, lineage
marker; MLP, multilineage progenitor; p-NK, NK lineage–committed
progenitor; p-T, T cell lineage–committed progenitor; p-T/NK, bipo-
tent progenitor generating T and NK cells; SCF, stem cell factor. 
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NK and T Cell Progenitors in the Fetal Thymus
 
In the mouse, it has been suggested that the thymic T
cell progenitors are T/NK bipotent. Rodewald et al. (5)
showed that the CD4
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CD8
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TCR
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Fc
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RII/III (FcR)
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population of FT was able to generate both T and NK
cells. It was further shown that the c-kit
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NK1.1
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 subpop-
ulation of CD44
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CD25
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 FT cells has the potential to gen-
erate both NK and T cells (7). The intimate relationship
between T and NK lineages has also been shown by ge-
netic analyses. Knockout of the common 
 
g
 
 chain (22) or
the Janus kinase 3 (23) gene resulted in depletion of NK
cells in addition to T and B cells, and overexpression of the
human CD3
 
e
 
 gene in the mouse brought about complete
depletion of both T and NK cells (24). More direct evi-
dence supporting the presence of bipotent progenitors gen-
erating T and NK cells (p-T/NK) has been shown in the
investigation of human FT progenitors. Sanchez et al. (25)
showed that T cells were generated from a pool of cells
(
 
z
 
1,000 cells) from many human FT cell colonies, all of
which were able to give rise to NK cells when cultured in
the presence of IL-2, by coculturing with a deoxyguanosine
(dGuo)-treated murine FT lobe. Moreover, they have shown
that thymic NK progenitors can be phenotypically sepa-
rated from T cell progenitors (26), strongly suggesting that
commitment to T and NK cell lineages occurs in the FT.
However, it is still unclear at what stage the bipotent pro-
genitor branches to unipotent T and NK progenitors. In
this study, we established for the first time a clonal assay
system that is effective in determining the developmental
potential of individual progenitors toward T and NK cells.
With this clonal assay, we verified the presence of p-T/NK
not only in the earliest CD44
 
1
 
CD25
 
2
 
 population, but also
in the CD44
 
1
 
CD25
 
1
 
 population of the FT. The presence
of a large number of NK lineage–committed progenitors
(p-NK) was also disclosed in the early FT subpopulations.
T cell lineage–committed progenitors (p-T) were shown to
increase with the progress of the differentiation stage, whereas
NK progenitors decreased reciprocally.
 
Materials and Methods
 
Mice.
 
Adult C57BL/6 (B6) mice were purchased from SLC.
B6Ly5.1 mice were maintained in our animal facility. Embryos at
various stages of gestation were obtained from time-mated preg-
nant B6Ly5.1 mice.
 
mAbs.
 
The following antibodies were used: PE–anti-Thy1.2
(5a-8; Caltag), biotinylated anti-NK1.1 and PE–anti-NK1.1
(PK136; PharMingen), PE–anti-CD45 (30F11.1; PharMingen),
PE–anti-CD122 (TM-
 
b
 
1; PharMingen), FITC–anti-CD3
 
e
 
 (145-
2C11; PharMingen), allophycocyanin (APC)–anti-CD3 (CT-CD3;
Caltag), FITC–anti-CD25 (PC61; PharMingen), PE–anti-CD44
(IM7.8.1; Caltag), APC–anti-CD8 and FITC–anti-CD8 (YTS169.4;
Caltag), APC–anti-CD4 and PE–anti-CD4 (GK1.5; Caltag),
FITC anti–TCR-
 
g
 
/
 
d
 
 (GL-3; Caltag), and PE anti–TCR-
 
a
 
/
 
b
 
(H57-597; Caltag). Anti-FcR (2.4G2) and anti-Ly5.2 (AL1-4A2,
donated by Dr. I.L. Weissman, Stanford University, Stanford, CA)
were labeled with FITC in our laboratory. Anti-TER119 (estab-
lished by Dr. T. Kina in our laboratory), anti-CD44 (IM7.8.1),
anti-B220 (RA3-6B2), anti–Mac-1 (M1/70), and anti–Gr-1
(RA3-8C5) were biotinylated in our laboratory. Anti–c-kit (ACK-2;
 
donated by Dr. S.-I. Nishikawa, Kyoto University) and anti-
Ly5.1 (A20-1.7; donated by Dr. Y. Saga, Banyu Seiyaku, Tokyo,
Japan) were conjugated with Cy5 using a labeling kit (Biological
Detection Systems). For biotinylated antibodies, Cy5-streptavidin
(Caltag) was used as the secondary reagent.
 
Growth Factors.
 
Recombinant murine (rm)IL-7 was donated by
Dr. T. Sudo (Basic Research Lab, Toray, Kanagawa, Japan). Com-
mercially available recombinant murine stem cell factor (rmSCF),
rmIL-2, and rmIL-15 (all from Genzyme) were also used.
 
Staining and Sorting of Progenitor Cells.
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 and FcR
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 sub-
populations of CD44
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CD25
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 FT cells were obtained from fe-
tuses at 12 d postcoitum (dpc) as described previously (19). To iso-
late CD44
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CD25
 
2
 
 and CD44
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 cells in the lineage marker
(Lin)
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CD3
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CD4
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CD8
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 population, 14-dpc FT cells were stained
with biotinylated Lin (anti-TER119, anti–Mac-1, anti–Gr-1,
anti-NK1.1, and anti-B220), washed, and then stained with a
mixture of Cy5-streptavidin, APC–anti-CD4, APC–anti-CD8,
APC–anti-CD3, FITC–anti-CD25, and PE–anti-CD44. Cells were
subsequently sorted using a FACS Vantage™ (Becton Dickin-
son). In sorting CD122
 
1
 
 cells, 14-dpc FT cells were stained with
the same mAbs as above except that PE–anti-CD122 was used
instead of PE–anti-CD44.
 
Cytokine-supplemented High Oxygen Submersion Culture.
 
The
method for high oxygen submersion (HOS) culture has been de-
scribed in detail elsewhere (27). Single dGuo-treated lobes were
placed into wells of a 96-well V-bottomed plate (Nalge Nunc In-
ternational), to which progenitors were added. The plates were
centrifuged at 150 
 
g
 
 for 5 min at room temperature, placed into a
plastic bag (Ohmi Oder Air Service), and the air inside was re-
placed by a gas mixture (70% O
 
2
 
, 25% N
 
2
 
, 5% CO
 
2
 
). The plastic
bag was incubated at 37
 
8
 
C. The cultures were maintained in
RPMI 1640 medium (GIBCO BRL) supplemented with 10% FCS
(M.A. Bioproducts), 
 
l
 
-glutamine (2 mM), sodium pyruvate (1 mM),
sodium bicarbonate (2 mg/ml), nonessential amino acid solution
(0.1 mM; GIBCO BRL), 2-ME (5 
 
3
 
 10
 
2
 
5
 
 M), streptomycin
(100 
 
m
 
g/ml), and penicillin (100 U/ml). Culture medium was
also supplemented with various cytokines to promote the growth
of NK cells (see Results). Medium was replaced by half every 5 d.
After 10 d of culture, cells inside and outside the FT lobe were
harvested from each well. One fifth of each sample was stained
with FITC–anti-Ly5.2, PE anti–Thy-1, and Cy5–anti-Ly5.1 to
be screened for the presence of progenitor type (Ly5.1
 
1
 
) cells and
expression of Thy-1
 
 
 
on these cells. The samples containing Ly5.1
 
1
 
cells were selected for further analysis. The remaining four fifths
of cells from the selected samples were divided into four groups.
One group was stained with FITC–anti-CD3
 
e
 
, PE–anti-NK1.1,
and Cy5–anti-Ly5.1, the second with FITC–anti-CD8, PE–anti-
CD4, and Cy5–anti-Ly5.1, and the third with FITC anti–TCR-
 
g
 
/
 
d
 
, PE anti–TCR-
 
a
 
/
 
b
 
, and Cy5–anti-Ly5.1. Surface phenotype
was analyzed by a FACS Vantage™. The remaining group was
used for the analysis of TCR gene rearrangement.
 
Cytotoxic Assay.
 
The cytotoxic assay was carried out as re-
ported previously (28). Yac-1 cells were used as target cells. In
brief, target cells were labeled with PKH67 green fluorescence dye
(Sigma Chemical Co.) and mixed with various numbers of effector
cells. The mixture was incubated at 37
 
8
 
C for 4 h in a V-bottomed
96-well microplate. Culture medium was the same as that used in
HOS cultures. Dead cells were stained with propidium iodide red
fluorescence dye (Sigma Chemical Co.), and the proportion of
propidium iodide–stained cells (dead cells) among PKH67-stained
cells was determined by analyzing with a FACS Vantage™.
 
PCR Analysis of TCR-
 
b
 
 and TCR-
 
g
 
 Gene Rearrangement.
 
One fifth of the cells harvested from each sample (see preceding 
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section) was subjected to PCR analysis. To prepare genomic DNA,
3,000 cells were resuspended in 20 
 
m
 
l of 1
 
3
 
 PCR buffer (10 mM
Tris-HCl, pH 9.0, 50 mM KCl, and 1.5 mM MgCl
 
2
 
) including
0.45% NP-40, 0.45% Tween 20, and 1.2 
 
m
 
g of Proteinase K
(Sigma Chemical Co.), and incubated at 55
 
8
 
C for 1 h, then 95
 
8
 
C
for 10 min. Samples of these disrupted cells were used as templates
for PCR amplification. Primers were: 5
 
9
 
 of D
 
b
 
2, 5
 
9
 
-GCACCTGT-
GGGGAAGAAACT-3
 
9
 
; 3
 
9
 
 of J
 
b
 
2.6, 5
 
9
 
-TGAGAGCTGTCTCC-
TACTATCGATT-3
 
9
 
; V
 
g
 
4
 
, 5
 
9
 
-AGTGTTCAGAAGCCCGAT-
GCA-3
 
9
 
; 3
 
9
 
 of J
 
g
 
1
 
, 5
 
9
 
-AGAGGGAATTACTATGAGCT-3
 
9
 
. The
reaction volume was 20 
 
m
 
l, containing 5 
 
m
 
l of the cell extract,
1.5 
 
m
 
l of 10
 
3
 
 PCR buffer, 0.16 
 
m
 
l of 25 mM dNTPs, 4 pmol of
each primer, and 0.6 U of Taq polymerase (Life Technologies).
Thermocycling conditions were as follows: 5 min at 94
 
8
 
C fol-
lowed by 35 cycles of 1 min at 94
 
8
 
C, 1 min at 60
 
8
 
C for D-J
 
b
 
 re-
arrangement or at 55
 
8
 
C for V-J
 
g rearrangement, 2 min at 728C, and
finally 10 min at 728C. The PCR products were applied to a 1.2%
agarose gel, electrophoresed, and stained with ethidium bromide.
Results
Modification of the FT Organ Culture System to Support the
Development of T and NK Cells. We first tried to establish
a culture system capable of generating T and NK cells. This
was attained by modifying the MLP assay system that was
effective in investigating the developmental capability of
progenitors toward T, B, and myeloid lineages (20).
Since FT contains a small number of NK cells as well as
NK progenitors (29), it is expected that dGuo-treated FT
lobes support the differentiation of NK cells. Cytokines IL-2
and IL-15 were used for promoting the growth of NK cells
in FT organ culture. FT cells from 12-dpc fetuses (100 cells)
of B6Ly5.1 mice, which are exclusively CD441CD252
(see Fig. 4 A for flow cytometric profiles), were seeded to
each well of a V-bottomed 96-well plate, in which a dGuo-
treated FT lobe (B6) had been placed. IL-2, IL-15, or a
cocktail of these and other cytokines was added, and the
plate was incubated under HOS conditions for 10 d. Cells
were harvested, counted, and assayed for expression of T and
NK cell markers on donor-derived (Ly5.11) cells. Table I in-
dicates that the cell recovery increased slightly by the addi-
tion of cytokines, and in all groups .90% of the recovered
cells were Thy-11. Without cytokines, z40% were CD31
NK1.12 (T cells), whereas only 3% were CD32NK1.11 cells
(NK cells). Addition of IL-2 or IL-15 dramatically increased
the proportion of NK cells, while the proportion of T cells
declined reciprocally. The effect of IL-2 or IL-15 in support-
ing the generation or growth of NK cells is compatible with a
previous report (30). Addition of IL-7 and SCF does not
show any prominent influence on the cell recovery or pro-
portions of T and NK cells. However, these factors are
supportive for improving the seeding efficiency in the single
progenitor assay (data not shown). In the following experi-
ments, we used a cocktail of IL-2 (25 U/ml), IL-7 (50 U/ml),
and SCF (10 ng/ml) as the agent modifying FT organ culture
to evenly support the development of NK and T cells.
Characterization of NK Cells Generated in the Modified FT
Organ Culture. The time course of T and NK cell genera-
tion in FT organ cultures with or without cytokine cocktail
was investigated. FT cells from 12-dpc fetuses (100 cells)
were cultured with a dGuo-treated lobe in the presence or
absence of a cytokine cocktail (IL-2, IL-7, and SCF). At var-
ious days after the culture, cells were harvested, counted, and
analyzed for their surface phenotypes. Numbers of CD31
NK1.12 and CD32NK1.11 cells were plotted against culture
days (Fig. 1, A and B). The results indicate that the genera-
tion or growth of NK cells is highly dependent on exoge-
nous cytokines, and that the NK cell generation in cytokine-
supplemented cultures preceded T cell generation by z1 d.
Fig. 1 C shows the representative flow cytometric profiles
for expression of NK1.1 versus CD3, CD4 versus CD8, and
TCR-a/b versus TCR-g/d on cells generated in cultures
with or without the cytokine cocktail. These results indicate
Table I. Effect of Various Cytokines on the Generation of T and NK Cells in FT Organ Cultures
Cytokine*
No. of cells
recovered‡
Percentage
Thy-11 CD31NK1.12 CD32NK1.11
 (3103)
None 83 6 21 96 6 2 41 6 33  6 1
IL-2 (25) 123 6 5 92 6 3 24 6 3 19 6 3§
IL-2 (100) 110 6 11 92 6 4 18 6 2 36 6 3
IL-15 (100) 113 6 12 95 6 2 17 6 2 38 6 3
IL-2 (50) 1 IL-15 (50) 150 6 30 94 6 3 16 6 2 40 6 3
IL-7 (50) 1 SCF (10) 120 6 13 92 6 2 38 6 22  6 1
IL-2 (25) 1 IL-7 (50) 1 SCF (10) 130 6 20 91 6 3 28 6 2 21 6 3
100 12-dpc FT cells (B6Ly5.1) were cultured in each well in the presence of a dGuo-treated lobe (B6) and cytokines for 10 d.
*Numbers in parentheses indicate the dose of cytokines added to the culture medium. The dose of IL-2 and IL-7 is expressed in U/ml; the dose of
IL-15 and SCF is expressed in ng/ml.
‡Mean cell number 6 SD of three wells.
§NK cells are found mainly outside the lobe; T cells are found mainly in the lobe.1620 NK and T Cell Progenitors in the Fetal Thymus
that the cytokine cocktail used here enhanced the generation
of NK cells without modulating T cell generation.
We next investigated whether the NK1.11 cells generated
in cytokine-supplemented FT organ cultures were func-
tional as NK cells. Cells were harvested from cytokine-sup-
plemented FT organ cultures seeded with 12-dpc FT cells
(100 cells), and CD32NK1.11 cells and CD32NK1.12 cells
were isolated with a flow cytometer. These cells were ex-
amined for killer activity by culturing with the NK-sensi-
tive cell line Yac-1 at various E/T ratios. Fig. 2 shows that
NK1.11 cells but not NK1.12 cells are cytotoxic, indicat-
ing that the NK1.11 cells generated in the cytokine-supple-
mented FT organ culture are functional NK cells.
Identification of p-T/NK, p-T, and p-NK in the FT by
Clonal Assay. Individual cells in the CD441CD252 popu-
lation from 14-dpc FT (B6Ly5.1) were seeded in the wells in
which a dGuo-treated FT (B6) lobe had been placed (Fig.
3 A). The culture medium was supplemented with IL-2,
IL-7, and SCF. After 10 d of culture under HOS conditions,
Figure 1. In vitro generation of T and NK cells from FT progenitors.
Unfractionated FT cells (102) from 12-dpc B6Ly5.1 fetuses were cultured
with a dGuo-treated FT lobe (B6) in the absence or presence of IL-2 (25
U/ml), IL-7 (50 U/ml), and SCF (10 ng/ml). At various days of culture,
cells were collected from each well, counted, and analyzed by a flow cy-
tometer. A and B show the kinetics of generation of CD31NK1.12 and
CD32NK1.11 cells, respectively. (C) Representative flow cytometric
profiles of cells recovered 10 d after culture for expression of NK1.1 vs.
CD3, CD4 vs. CD8, and TCR-a/b vs. TCR-g/d on Ly5.11 cells. Pro-
files of newborn thymus cells are shown for comparison.
Figure 2. Cytolytic activity of
NK1.11 cells derived from 12-dpc
FT progenitors. Unfractionated
FT cells (102) from 12-dpc fetuses
were cultured together with a
dGuo-treated FT lobe in the pres-
ence of a cytokine cocktail (see
legend to Fig. 1). After 10 d of
culture, cells were recovered and
pooled from three wells, then
stained in three colors with anti-
Ly5.1, anti-CD3, and anti-NK1.1.
Ly5.11CD32NK1.11 cells and
Ly5.11CD32 NK1.12 cells were
obtained by FACS® sorting, and were assayed for cytolytic activity against
the target cell line Yac-1 as detailed in Materials and Methods.
Figure 3. Representative flow cytometric profiles of cells derived from
single FT progenitors. (A) Procedure of the clonal assay culture is shown.
Single CD441CD252 FT cells (14 dpc) were picked up under micro-
scopical visualization, then seeded into the wells where a dGuo-treated
FT lobe had been placed. The culture medium used was supplemented
with a cytokine cocktail (see legend to Fig. 1). Cells were cultured under
HOS conditions for 10 d. (B) Examples of the flow cytometric profiles of
cells generated from p-NK, p-T, and p-T/NK are shown. Cell recoveries
in these clones were 2.4 3 104, 8.0 3 104, and 2.0 3 105, respectively.1621 Ikawa et al.
cells were harvested from each well for flow cytometric
analysis. Expression of T and NK cell markers was exam-
ined by gating Ly5.11 cells. Surface phenotypes of cells
derived from three types of progenitors identified in this
experiment are shown in Fig. 3 B. The progenitors gener-
ating NK1.11 cells but not CD31 cells were determined to
be p-NK (Fig. 3 B, left panels), whereas those generating
only CD31 cells were determined to be p-T (middle pan-
els). In addition, the presence of p-T/NK was shown un-
ambiguously (right panels). The T cells generated from a p-T
as well as from a p-T/NK express CD4 and/or CD8 as
well as TCR-a/b or TCR-g/d. The generation of NKT-
like cells expressing both CD3 and NK1.1 was seen in the
case of p-T/NK. Such NKT-like cells were also generated
from p-T but not from p-NK when the culture period was
extended (data not shown).
In our previous study investigating the developmental
potential of thymic progenitors toward T, B, and myeloid
lineages, it was indicated that a large majority of the pro-
genitors in FT cells was committed to the T cell lineage (21).
Because the culture conditions used in this study were un-
able to support the generation of NK cells, both p-T/NK
and p-T should have been defined as “p-T.”
When Do the p-T and p-NK Split from Bipotent p-T/NK?
Subpopulations of 12- and 14-dpc FT cells (Fig. 4 A) were
used as the progenitor source. These subpopulations were
sorted, and the single cells (total 50 cells in each group)
were cultured for 10 d in cytokine-supplemented FT organ
culture as in the preceding section. Cells were recovered
from each well, and analyzed with a flow cytometer. Three
types of progenitors were found to be present in these sub-
populations, and these three types were the same as those
seen in Fig. 3 B.
The distribution of different types of progenitors in sub-
populations of 12- and 14-dpc FT cells is shown in Fig. 4,
B and C, respectively. It was found that all T cell progeni-
tors in the most immature CD441CD252FcR2 (FcR2)
population of 12-dpc FT were p-T/NK, and the frequency
of the p-T/NK in this population is equivalent to that de-
termined to be “p-T” in our previous investigation per-
formed with the MLP assay (21). Quite a large number of
p-NK also exists in this population. A small number of p-T
appears at the next CD441CD252FcR1 (FcR1) stage, but
p-T/NK and p-NK still predominate in this population. In
the CD441CD252 population of 14-dpc FT, the proportion
of p-T becomes higher than in 12-dpc FT. It is also found
that p-NK is the largest in number in this population. A
prominent increase of p-T was seen at the CD441CD251
stage. Of interest is that p-T/NK and p-NK still exist in
this stage. At the CD442CD251 stage, most of the cells no
longer express progenitor activity, although a very small
number of p-T can be seen (data not shown). The results
shown in Fig. 4 suggest that the NK potential is retained in
the T cell progenitor until just before the TCR-b gene re-
arrangement begins. In contrast, p-NK can split from p-T/
NK at any stage of early T cell development in the FT.
NK Lineage Commitment Occurs before the Rearrangement of
TCR Genes. It is well known that NK cells do not ex-
press TCR on their surface, nor do they rearrange TCR
genes (3). However, because the NK cells generated in the
present study are artificially induced from thymic progeni-
tors by culturing them with a thymic lobe in the presence
Figure 4. Frequency and total number of dif-
ferent types of progenitors in subpopulations of
12- and 14-dpc FT cells. (A) Flow cytometric
profiles of 12- and 14-dpc FT cells are shown.
Numbers in panels represent percentage of cells.
Cells in subpopulations gated with bars or rect-
angles in A served for the clonal assay (see Fig.
3 A). In all subpopulations, 50 individual cells
were investigated. (B and C) The numbers of
the different types of progenitors detected
among 50 cells are scored (upper scales). In cal-
culating the total number of progenitors in an
FT (lower scales), the numbers of cells per 12-dpc
FT and 14-dpc FT were regarded as 1,000 and
10,000, respectively.1622 NK and T Cell Progenitors in the Fetal Thymus
of exogenous cytokines, the possibility could not be ruled
out that the progenitors that had already initiated their
TCR gene rearrangement were induced to become NK
cells. DNA was extracted from NK and T cells derived from
single p-T/NK, from NK cells derived from single p-NK,
and from T cells derived from single p-T. Rearrangement
of TCR-b and TCR-g genes was examined by PCR using
the primer pairs shown in Fig. 5. It is shown that multiple
rearrangements had occurred at the Db-Jb and Vg-Jg re-
gions in all T cells derived from single progenitors. In marked
contrast, TCR gene rearrangement was not observed in NK
cells regardless of origin, indicating that the split to the NK
progenitors ceases before rearrangement of the TCR-b gene.
Enrichment of p-NK in the IL-2Rb1 Population of FT.
To ensure the existence of p-NK in the FT, we tried to
isolate a population containing exclusively p-NK. For iso-
lation of p-NK, we used an mAb to CD122 (IL-2/15Rb),
because it has been suggested that the NK progenitors ex-
press this molecule (6, 31).
Lin2CD441CD252 cells from 14-dpc FT can be sepa-
rated into CD1222 and CD1221 subpopulations (Fig. 6 A).
In this experiment, anti-NK1.1 mAb is included in the lin-
eage (Lin) markers. Cells enclosed in the rectangles (right
panel of Fig. 6 A) were sorted, and served for the single cell
assay to determine NK and T cell generating potential. The
results, shown in Fig. 6 B, indicate that the CD1222 popu-
lation contains all three types of progenitors, whereas only
p-NK were detected in the CD1221 population. More-
over, p-NK were highly enriched in the CD1221 popula-
tion: 17 out of 50 cells examined were p-NK. Failure to
detect any p-T/NK or p-T indicates that the frequency of
these progenitors in this population is ,1/50. Such a low
frequency of p-T in the CD1221 population was con-
firmed by culturing single cells with a dGuo-treated lobe in
the absence of exogenous IL-2 (data not shown). On the
other hand, previous studies in which 103 CD1221 FT cells
were cultured with a dGuo-treated FT indicated that this
population retains the potential to generate T cells (6, 32).
Thus, the CD1221 population might contain a very small
number of p-T, but the large majority of CD1221 progen-
itors are NK lineage committed.
Discussion
We have previously shown that only progenitors restricted
to T, B, or myeloid lineage, but not multipotent progenitors,
exist in the FT (21). However, the assay system used in
these experiments was not designed to support the genera-
tion of NK cells. In this study, we succeeded in establishing
a new assay system capable of determining the develop-
mental potential of a single progenitor toward T and/or
NK lineages. By examining individual cells with this assay
system, the existence of bipotent p-T/NK in FT was un-
ambiguously shown. The unipotent p-T and p-NK detected
in this study are also considered to reflect the commitment
status in vivo for the following reasons: (a) p-T or p-NK are
enriched or purified in subpopulations of FT cells; (b) the
addition of IL-2 to the culture medium made p-NK come
into view without reducing the frequency of progenitors
Figure 5. NK cells retain their TCR-b and
TCR-g locus in the germline configuration. The
Db2-Jb2 gene rearrangement (A) and Vg4/Vg3-
Jg1 gene rearrangement (B) in cells derived from
single p-T/NK, p-NK, and p-T were investigated.
As a positive control, unfractionated adult thymo-
cytes (AT) were used. The DNA equivalent to 750
cells was PCR amplified in each sample.
Figure 6. The CD1221 population of FT cells contains exclusively
p-NK. (A) Flow cytometric profiles of 14-dpc FT cells. (B) Single
CD441CD252CD1222 or CD441CD252CD1221 cells (50 cells each)
enclosed with rectangles in the right panel of A were cultured with a
dGuo-treated FT lobe in the presence of the cytokine cocktail (see legend
to Fig. 3). The numbers of the different types of progenitors detected
among 50 CD1222 and 50 CD1221 cells are scored.1623 Ikawa et al.
with T cell potential (our unpublished data), indicating that
the progenitors detected as p-NK are distinct from p-T/NK
or p-T; (c) detection of p-T/NK but not p-T in the FcR2
subpopulation of 12-dpc FT indicated that the NK poten-
tial retained by a p-T/NK–type T cell progenitor is very
efficiently expressed in this assay; and (d) addition of higher
doses of IL-2 (50–100 U/ml) did not increase the frequency
of p-NK or p-T/NK (data not shown), strongly suggesting
that the progenitors detected as p-T retain no NK potential.
With this clonal assay, we clarified that all of the T cell
progenitors previously determined in the CD441CD252
FcR2 population of 12-dpc FT (21) were bipotent p-T/NK
(Fig. 4). It has recently been shown that a population capa-
ble of generating both T and NK cells is present in fetal
spleen and fetal blood of 13–16 dpc fetuses (33, 34), and we
have found that a large number of p-T/NK exist in 12-dpc
fetal liver (FL; our unpublished data). These findings
strongly suggest that the p-T/NK that emerged in prethy-
mic tissues have migrated into the FT. This study further
showed that the earliest CD441CD252FcR2 population
contained quite a large number of p-NK in addition to
p-T/NK. This is in marked contrast to the detection of
only a very small number of p-T at early stages (Fig. 4 B). It
is likely that the early thymic p-T/NK generate p-NK
through uneven cell division, retaining their T/NK bipo-
tent activity. However, the possibility cannot be ruled out
that some of these p-NK are of extrathymic origin, as the
p-NK have also been detected in FL (our unpublished data).
A rapid increase in the proportion of p-T, which are un-
able to generate NK cells, between the CD441CD252 and
CD441CD251 stages (Fig. 4) may indicate that progenitors
are committed to the T cell lineage immediately before
TCR-b gene rearrangement. The predominance of p-T at
the CD441CD251 stage is compatible with previous find-
ings that the CD441CD251 population scarcely retains NK
potential (9, 17). Consistent with this is the finding that the
expression of T cell lineage–restricted molecules becomes
prominent at this stage (19, 35). It remains to be clarified
whether the increase of p-T in this population is due to
multiple uneven splits of p-T from p-T/NK or to the pro-
liferation of p-T themselves at this stage.
It is well known that NK cell development is indepen-
dent of the thymus, and NK activity in nu/nu mice is re-
ported to be higher than in normal euthymic mice (4).
Thus, a question to be answered is why the progenitors mi-
grating into the thymus retain NK potential. It is possible
that the thymus supplies NK cells to peripheral lymphoid
tissues during fetal through neonatal ages, since NK cells
are generated first in the FT during ontogeny (29, 36). An
alternative interpretation could be that the NK progenitors
or a small number of NK cells generated in the FT play a
part in inducing the architecture of the thymic microenvi-
ronment. Such an idea is based on recent findings that pro-
genitors expressing surface lymphotoxin, which retain NK
potential, participate in forming lymph nodes and Peyer’s
patches (37, 38). However, it seems unlikely that NK pro-
genitors are indispensable for the construction of the thy-
mic environment, since isolated p-T can produce T cells in
the dGuo-treated FT lobe (Figs. 3 and 5). Moreover, thy-
mic T cell development is normal in lymphotoxin knock-
out mice (39) and Id2 knockout mice (40) that lack lymph
nodes and Peyer’s patches. There may be no necessity for
splitting off NK potential before entering the thymus, since
NK potential does not seem to disturb T cell generation in
the thymus. On the other hand, it is unlikely that the role
of p-NK is to supply NKT cells, as NKT-like cells are gen-
erated from p-T but not from p-NK (see text referring to
Fig. 3). More detailed investigations are necessary to clarify
the role of p-NK or NK cells in the thymus.
Fig. 7 illustrates the stages of commitment of p-T/NK to
p-T and p-NK revealed by this study. All T cell progenitors
in FL are T/NK bipotent, although p-NK also exist in FL
(our unpublished data). The developmental potential toward
T and NK lineages is intimately kept together until imme-
diately before TCR-b gene rearrangement begins. Never-
theless, p-NK are generated at a rather broad range of dif-
ferentiation stages, including prethymic stages. Delivery of
p-NK in the FT begins at the earliest CD441CD252FcR2
Figure 7. A model for NK and T cell lin-
eage commitment in the murine FT. The T
cell progenitors migrating into the FT are bi-
potent p-T/NK. Commitment of p-T/NK
to p-NK occurs at a broad range of early dif-
ferentiation stages, whereas commitment to
p-T mainly occurs immediately before the
TCR-b rearrangement. CD441CD252 cells
in 12-dpc FT comprise FcR2 and FcR1
populations (see Fig. 4), whereas a majority
of those in 14-dpc FT are FcR1 (reference
19). A portion of p-NK in 14-dpc FT ex-
press CD122. The width of the white arrows
approximately correlates with the rate of p-T
and p-NK generation. It is unclear whether
p-NK also immigrate from extrathymic tis-
sues (broken arrow).1624 NK and T Cell Progenitors in the Fetal Thymus
stage, and continues up to the CD441CD251 stage. In con-
trast, commitment to the T cell lineage, or the delivery of
p-T, occurs mainly at the CD441CD251 stage, which is im-
mediately before TCR-b gene rearrangement begins. Such
an intimate association of NK potential to the T cell lineage
may provide circumstantial evidence for the proposal that T
cells have evolved from a prototype of NK cells.
To date, no signals, either extracellular or intracellular,
mediating commitment of p-T/NK to p-T and p-NK have
been determined. It has previously been shown that high
doses of IL-2 and IL-15 may interfere with the cell fate
choice of progenitors between T and NK lineages (6).
Knockout of IL-2/15Rb (41) or IL-15Ra (42) gene results
in the complete absence of NK cells. Targeting of the IFN
regulatory factor 1 (IRF-1) gene, which is indispensable for
IL-15 production, also brings about deletion of NK cells
(43). However, the role of cytokines or cytokine receptors
seems to be mostly related to the promotion or inhibition of
the growth of precursors and/or mature cells rather than to
lineage commitment. Some transcription factors (GATA-3,
TCF-1) have been reported to be required for T cell devel-
opment (44), but it has not yet been clarified whether these
molecules are also involved in NK cell development. Mol-
ecules that seem to be more directly involved in the branch-
ing point between T and NK lineages are natural dominant
negative helix-loop-helix factors Id2 and Id3. Transduction
of the Id3 gene into CD341 cells from human FL was found
to result in enhancement of NK cell generation at the cost
of T cell generation (45). In the Id2-deficient mice, NK
cell development was found to be severely depleted with-
out affecting T cell development (40). A transcription fac-
tor, Ets-1, was also found to play an important role in the
generation of NK but not T cells (46). A combination of
these genetic investigations and the single progenitor assay
established in this study will contribute significantly to the
elucidation of molecular and cellular mechanisms underlying
the commitment and differentiation of T and/or NK cells.
We are currently setting up such an experimental system.
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